Found 11 matching trials
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)
PHASE3Primary Objective:
To assess efficacy of daily SAR442168 compared to a dai...
Location
University of Alabama MS Center-Site Number:8400013
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)
PHASE3To compare the efficacy and safety of remibrutinib versus teriflunomide in ...
Status
Active Not Recruiting
Location
Ctr for Neurology and Spine
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)
PHASE3Primary Objective:
To assess efficacy of daily SAR442168 compared to a dai...
Location
North Central Neurology Associates, PC-Site Number:8400009
A Phase 1, 2-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASLAN003 in Healthy Elderly Subjects
PHASE1This is a Phase 1, randomised, single-blind, placebo-controlled, 2 stage st...
Location
Multiple Locations
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
PHASE3A study to evaluate the efficacy and safety of fenebrutinib on disability p...
Status
Active Not Recruiting
Location
University of Alabama Birmingham
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)
PHASE3To compare the efficacy and safety of remibrutinib versus teriflunomide in ...
Status
Active Not Recruiting
Location
AZ Integrated Neuro and Spine
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
PHASE3To compare the efficacy and safety of ofatumumab administered subcutaneousl...
Location
Novartis Investigative Site
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
PHASE3A study to evaluate the efficacy and safety of fenebrutinib on disability p...
Status
Active Not Recruiting
Location
North Central Neurology Associates
Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
PHASE3The primary objective was to demonstrate the effect of teriflunomide (HMR17...
Location
Investigational Site Number 8965
Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis
PHASE3Primary Objective:
To assess the effect of teriflunomide in comparison to ...
Location
North Central Neurology Associates, PC Site Number : 840003